Prothena Corporation plc

Prothena is a late-stage clinical company with expertise in protein dysregulation and a diverse pipeline of novel investigational therapies for rare peripheral amyloid and neurodegenerative diseases. We are committed to developing novel and transformative medicines to create a better future for people in critical need of new treatment options. Our diversified portfolio is designed to make a significant impact on rare peripheral amyloid. Prothena's success is driven by our people. Our shared humanity drives a passionate and unwavering commitment to apply high scientific rigor toward developing innovative new therapies for patients. We have ambitious goals and take every aspect of our mission seriously, except ourselves. Our values connect us – you will see and feel them come to life in all we do – together. At Prothena, our culture reflects our values which are brought to life every day by the following characteristics: Selfless Patients come first and we're in this together. Our environment is collaborative and we measure success through our collective accomplishments. Courageous Transformational innovation leads to novel treatments. "Tried-and-true" won't produce breakthroughs for patients – a pioneering spirit, willingness to accept risk and try new approaches will. Each individual and team is expected to bring their heart, experience and trust on our journey. Imaginative We value and encourage a creative approach across all aspects of our work. We challenge ourselves and each other to think beyond what is known and approach our work through a lens of continuous improvement. Joyful Humor and heart allow us to tackle the seriousness of our work. Excellence and fun are not at odds – we love what we do and enjoy the journey. For more information, please visit our website at http://www.prothena.com and follow us on Twitter @ProthenaCorp.